About Together
Together Pharma is building a scalable Israeli cannabis platform designed to combine market leadership, operational control, portfolio diversification and global growth.
Together’s model is built around operational control, market responsiveness and the ability to translate industry expertise into scalable commercial opportunities. The company combines a strong position in Israel’s medical cannabis market with international cultivation capabilities, global partnerships and a diversified portfolio designed to serve multiple patient segments, price tiers and product categories.
Together’s model is built around operational control, market responsiveness and the ability to translate industry expertise into scalable commercial opportunities.
The Israeli Cannabis Powerhouse
Together Pharma’s vision is to build a leading Israeli platform for regulated cannabis and cannabinoid-based healthcare, combining local market expertise, international infrastructure and disciplined execution.The company’s long-term ambition is to leverage its position in Israel, accumulated industry knowledge and operating capabilities to identify emerging market needs, develop relevant products and create scalable growth opportunities across regulated markets.
Complete Vertical Integration
Together operates across key stages of the medical cannabis value chain, from genetics and cultivation through processing, quality assurance, product development, marketing and distribution.This integrated structure provides greater control over product quality, supply continuity and commercial execution, while allowing the company to respond quickly to changing market conditions.
By managing multiple stages of the value chain within a single operating platform, Together is positioned to create efficiencies, maintain consistent standards and support growth across a broad range of products and markets.
Leadership Across Every Market Tier
Together’s position in the Israeli medical cannabis market is built on breadth, quality and availability.
The company maintains a diversified portfolio designed to address a wide range of patient needs, purchasing profiles and price points, from accessible value-oriented products to premium and craft offerings.Rather than relying on a single category or market segment, Together operates across multiple tiers of the market, allowing the company to adapt its offering as demand evolves and to maintain relevance across a broad customer base.
A Diversified House of Brands
Together operates a multi-brand portfolio that combines proprietary brands, selected genetics and international partnerships within one commercial platform. Its portfolio spans multiple positioning and price tiers, allowing each brand and product line to address a distinct market need while benefiting from Together’s shared infrastructure, regulatory expertise, quality systems, marketing capabilities and distribution network.
This House of Brands approach enables the company to broaden market coverage, introduce differentiated products and reduce dependence on the performance of any single brand or category.
Beyond Traditional Cannabis
Together continues to expand beyond traditional medical cannabis flower by developing capabilities in pharmaceutical cannabis oils, cannabinoid-based products and advanced delivery formats.
The company’s innovation strategy is focused on creating products that respond to evolving patient preferences, changing consumption patterns and the growing demand for more precise, convenient and differentiated forms of administration.
These initiatives are intended to strengthen Together’s core medical cannabis activity while opening additional opportunities across adjacent healthcare and cannabinoid-based markets.
From Market Leadership to Global Growth
Together’s growth strategy is focused on strengthening its core position in Israel while developing additional growth engines across products, partnerships and international markets.
Key areas of focus include expanding the company’s product portfolio, deepening international collaborations, advancing cannabinoid-based products and new delivery formats, and leveraging the company’s international infrastructure to support activity in additional regulated markets.
Together’s objective is to translate its existing market position, operating capabilities and international platform into a broader, more scalable business with multiple long-term growth drivers.
